Keybanc Maintains Overweight on Rapid Micro Biosystems, Lowers Price Target to $5

Benzinga Newsdesk www.benzinga.com Negative 90.9%

Neg 90.9% Neu 0% Pos 0%

Keybanc analyst Paul Knight maintains Rapid Micro Biosystems (NASDAQ:RPID) with a Overweight and lowers the price target from $8 to $5.